XOMA Corp.

( )
XOMA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.11%163.400.7%$1332.29m
LLYEli Lilly & Co. 0.59%323.501.1%$1074.17m
ABBVAbbVie, Inc. 0.87%139.501.9%$859.53m
PFEPfizer Inc. 0.58%44.370.9%$802.32m
BMYBristol-Myers Squibb Co. -0.03%70.521.0%$772.56m
MRKMerck & Co., Inc. 0.39%87.900.7%$713.21m
AZNAstraZeneca Plc 1.55%56.411.0%$393.49m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%196.798.2%$217.39m
GSKGSK Plc 1.99%30.830.3%$213.67m
NVSNovartis AG 1.67%77.950.2%$205.02m
ATXIAvenue Therapeutics, Inc. 38.14%15.900.0%$192.44m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.485.4%$191.16m
IDXXIDEXX Laboratories, Inc. 1.12%340.463.9%$186.35m
HZNPHorizon Therapeutics Plc 0.00%64.265.4%$173.65m
SRPTSarepta Therapeutics, Inc. 0.00%109.9412.4%$136.73m

Company Profile

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.